109 related articles for article (PubMed ID: 9971877)
1. Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations.
Wagner TM; Hirtenlehner K; Shen P; Moeslinger R; Muhr D; Fleischmann E; Concin H; Doeller W; Haid A; Lang AH; Mayer P; Petru E; Ropp E; Langbauer G; Kubista E; Scheiner O; Underhill P; Mountain J; Stierer M; Zielinski C; Oefner P
Hum Mol Genet; 1999 Mar; 8(3):413-23. PubMed ID: 9971877
[TBL] [Abstract][Full Text] [Related]
2. BRCA2 germline mutations in male breast cancer cases and breast cancer families.
Couch FJ; Farid LM; DeShano ML; Tavtigian SV; Calzone K; Campeau L; Peng Y; Bogden B; Chen Q; Neuhausen S; Shattuck-Eidens D; Godwin AK; Daly M; Radford DM; Sedlacek S; Rommens J; Simard J; Garber J; Merajver S; Weber BL
Nat Genet; 1996 May; 13(1):123-5. PubMed ID: 8673091
[TBL] [Abstract][Full Text] [Related]
3. Screening of male breast cancer and of breast-ovarian cancer families for BRCA2 mutations using large bifluorescent amplicons.
Pages S; Caux V; Stoppa-Lyonnet D; Tosi M
Br J Cancer; 2001 Feb; 84(4):482-8. PubMed ID: 11207042
[TBL] [Abstract][Full Text] [Related]
4. Ten novel BRCA1 and BRCA2 mutations in breast and/or ovarian cancer families from northern Germany.
Kiechle M; Gross E; Schwarz-Boeger U; Pfisterer J; Jonat W; Gerber WD; Albacht B; Fischer B; Schlegelberger B; Arnold N
Hum Mutat; 2000 Dec; 16(6):529-30. PubMed ID: 11102986
[TBL] [Abstract][Full Text] [Related]
5. BRCA2 germline mutations in Cypriot patients with familial breast/ovarian cancer.
Hadjisavvas A; Charalambous E; Adamou A; Christodoulou CG; Kyriacou K
Hum Mutat; 2003 Feb; 21(2):171. PubMed ID: 12552570
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.
Phelan CM; Lancaster JM; Tonin P; Gumbs C; Cochran C; Carter R; Ghadirian P; Perret C; Moslehi R; Dion F; Faucher MC; Dole K; Karimi S; Foulkes W; Lounis H; Warner E; Goss P; Anderson D; Larsson C; Narod SA; Futreal PA
Nat Genet; 1996 May; 13(1):120-2. PubMed ID: 8673090
[TBL] [Abstract][Full Text] [Related]
7. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.
Shiri-Sverdlov R; Oefner P; Green L; Baruch RG; Wagner T; Kruglikova A; Haitchick S; Hofstra RM; Papa MZ; Mulder I; Rizel S; Bar Sade RB; Dagan E; Abdeen Z; Goldman B; Friedman E
Hum Mutat; 2000 Dec; 16(6):491-501. PubMed ID: 11102978
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer.
Schubert EL; Mefford HC; Dann JL; Argonza RH; Hull J; King MC
Genet Test; 1997; 1(1):41-6. PubMed ID: 10464624
[TBL] [Abstract][Full Text] [Related]
9. Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families.
Peelen T; van Vliet M; Bosch A; Bignell G; Vasen HF; Klijn JG; Meijers-Heijboer H; Stratton M; van Ommen GJ; Cornelisse CJ; Devilee P
Br J Cancer; 2000 Jan; 82(1):151-6. PubMed ID: 10638982
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.
Fernandes GC; Michelli RA; Galvão HC; Paula AE; Pereira R; Andrade CE; Felicio PS; Souza CP; Mendes DR; Volc S; Berardinelli GN; Grasel RS; Sabato CS; Viana DV; Mauad EC; Scapulatempo-Neto C; Arun B; Reis RM; Palmero EI
Oncotarget; 2016 Dec; 7(49):80465-80481. PubMed ID: 27741520
[TBL] [Abstract][Full Text] [Related]
12. Inherited BRCA2 mutations in African Americans with breast and/or ovarian cancer: a study of familial and early onset cases.
Kanaan Y; Kpenu E; Utley K; Adams-Campbell L; Dunston GM; Brody LC; Broome C
Hum Genet; 2003 Oct; 113(5):452-60. PubMed ID: 12942367
[TBL] [Abstract][Full Text] [Related]
13. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
Vehmanen P; Friedman LS; Eerola H; McClure M; Ward B; Sarantaus L; Kainu T; Syrjäkoski K; Pyrhönen S; Kallioniemi OP; Muhonen T; Luce M; Frank TS; Nevanlinna H
Hum Mol Genet; 1997 Dec; 6(13):2309-15. PubMed ID: 9361038
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of the BRCA2 gene in 16 breast/ovarian cancer Spanish families.
Osorio A; Robledo M; Martínez B; Cebrián A; San Román JM; Albertos J; Lobo F; Benítez J
Clin Genet; 1998 Aug; 54(2):142-7. PubMed ID: 9761393
[TBL] [Abstract][Full Text] [Related]
15. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
[TBL] [Abstract][Full Text] [Related]
16. Genetic testing for breast cancer susceptibility: frequency of BRCA1 and BRCA2 mutations.
Ganguly A; Leahy K; Marshall AM; Dhulipala R; Godmilow L; Ganguly T
Genet Test; 1997; 1(2):85-90. PubMed ID: 10464631
[TBL] [Abstract][Full Text] [Related]
17. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
18. High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer.
Grzybowska E; Zientek H; Jasinska A; Rusin M; Kozlowski P; Sobczak K; Sikorska A; Kwiatkowska E; Gorniak L; Kalinowska E; Utracka-Hutka B; Wloch J; Chmielik E; Krzyzosiak WJ
Hum Mutat; 2000 Dec; 16(6):482-90. PubMed ID: 11102977
[TBL] [Abstract][Full Text] [Related]
19. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene.
Gayther SA; Mangion J; Russell P; Seal S; Barfoot R; Ponder BA; Stratton MR; Easton D
Nat Genet; 1997 Jan; 15(1):103-5. PubMed ID: 8988179
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 and BRCA2 mutation analysis in 86 early onset breast/ovarian cancer patients.
Garvin AM; Attenhofer-Haner M; Scott RJ
J Med Genet; 1997 Dec; 34(12):990-5. PubMed ID: 9429140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]